Alpha-1 antitrypsin deficiency explained

What the condition is

Alpha-1 antitrypsin is a protein made mainly in the liver and released into the blood, where it travels to the lungs and protects delicate lung tissue from being broken down by the body's own enzymes. In alpha-1 antitrypsin deficiency, an inherited gene change means the liver either makes too little of this protein or makes a faulty form that gets stuck in the liver instead of reaching the lungs. As a result the lungs lose some of their protection, and the trapped protein can also stress the liver. Someone usually needs to inherit an affected gene from both parents to have significant deficiency. It is one of the more common serious inherited conditions in people of European background, though many affected people are never diagnosed.

How it affects the lungs and liver

The main concern is the lungs. Without enough protective protein, lung tissue can be broken down over time, leading to a type of long-term lung damage similar to emphysema, often at a younger age than usual — typically causing breathlessness, wheeze and a cough. Smoking dramatically speeds up this damage, so it is by far the most important thing to avoid. In some people, the faulty protein that gets stuck in the liver can cause liver inflammation, scarring or, occasionally, more serious liver disease; this can affect children as well as adults. Not everyone with the condition develops problems, and the severity varies widely, but knowing about it allows people to take steps that genuinely protect their lungs and liver.

How it is diagnosed

Diagnosis often begins when someone develops lung problems younger than expected, has a strong family history, or has unexplained liver disease. A simple blood test measures the level of alpha-1 antitrypsin protein in the blood, and if it is low, further blood tests can identify which faulty gene versions a person carries. Doctors may also assess the lungs with breathing tests and scans, and check the liver with blood tests and sometimes imaging. Because the condition is inherited, relatives of someone diagnosed may be offered testing, especially if they smoke or have symptoms. Making the diagnosis matters even when someone feels well, because it guides powerful protective steps such as never smoking.

How it is managed

There is no simple cure, so management focuses on protecting the lungs and liver and treating any problems that arise. By far the most important step is never smoking and avoiding second-hand smoke, as smoking hugely accelerates lung damage. People are encouraged to stay active, keep up with vaccinations that protect the chest such as flu and pneumonia jabs, and avoid heavy alcohol use to protect the liver. Lung symptoms are managed much like other long-term lung conditions, and liver problems are monitored and treated by specialists. In selected people with significant lung disease, specialist centres may consider treatments that aim to top up the missing protein. Care is usually shared with respiratory and, where needed, liver specialists.

Living well with the condition

Many people with alpha-1 antitrypsin deficiency live full lives, particularly if they have never smoked and keep their lungs and liver protected. Ongoing care usually includes monitoring lung function and liver health over time, staying physically active, keeping vaccinations up to date, and seeking help early for chest infections. Because the condition is inherited, families are often involved in testing and advice. Support groups can help people understand and adjust to a lifelong diagnosis. The practical message is empowering: while the condition cannot be undone, the single most powerful thing anyone with it can do — avoiding tobacco smoke completely — is fully within their control and dramatically improves the outlook.